ARCADIA-CSI: Cognition and Silent Infarcts

  • Das, Saurav (PI)
  • Pettigrew, Luther (Former PI)

Grants and Contracts Details


ARCADIA-CSI is an ancillary study to the ARCADIA trial that will add two outcomes (cognition and silent infarction) to the parent trial. The purpose of ARCADIA-CSI is to determine the effect of apixaban vs aspirin on these two additional outcomes in patients with stroke of unknown cause and atrial cardiopathy. Patients randomized in ARCADIA will be eligible for ARCADIA-CSI if they can undergo cognitive testing (English speakers with score
Effective start/end date7/1/191/8/24


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.